Probiotic effects of orally administered <i>Lactobacillus reuteri</i>‐containing tablets on the subgingival and salivary microbiota in patients with gingivitis. A randomized clinical trial

Abstract

The effect of L. reuteri administered in tablets resulted in a reduction in the number of selected periodontal pathogens in the subgingival microbiota, without an associated clinical impact.